CARGO THERAPEUTICS INC (CRGX) Stock Price, Quote, News and Overview
NASDAQ:CRGX - Nasdaq - US14179K1016 - Common Stock - Currency: USD
CRGX Quote, Performance and Key Statistics
CARGO THERAPEUTICS INC
NASDAQ:CRGX (1/30/2025, 5:58:42 PM)
After market: 3.365 -0.02 (-0.74%)3.39
-9.8 (-74.3%)
The current stock price of CRGX is 3.39 USD. In the past month the price decreased by -75.36%. In the past year, price decreased by -85.57%.
CRGX Latest News, Press Releases and Analysis
Let's take a look at the stocks that are in motion in today's session.
Keep an eye on the top gainers and losers in Thursday's session, as they reflect the most notable price movements.
Top stock movements in today's session.
Keep an eye on the top gainers and losers in Thursday's session, as they reflect the most notable price movements.
There are notable gap-ups and gap-downs in today's session.
Let's have a look at what is happening on the US markets on Thursday. Below you can find the gap up and gap down stocks in today's session.
Stay updated with the stocks that are on the move in today's pre-market session.
Before the opening bell on Thursday, let's take a glimpse of the US markets and explore the top gainers and losers in today's pre-market session.
CRGX Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABBV | ABBVIE INC | 16.34 | 310.40B | ||
| AMGN | AMGEN INC | 14.78 | 152.67B | ||
| GILD | GILEAD SCIENCES INC | 21.88 | 120.83B | ||
| VRTX | VERTEX PHARMACEUTICALS INC | 859.61 | 112.90B | ||
| REGN | REGENERON PHARMACEUTICALS | 15.04 | 75.06B | ||
| ARGX | ARGENX SE - ADR | N/A | 39.81B | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | N/A | 35.75B | ||
| BNTX | BIONTECH SE-ADR | N/A | 29.13B | ||
| ONC | BEIGENE LTD-ADR | N/A | 24.16B | ||
| NTRA | NATERA INC | N/A | 23.27B | ||
| BIIB | BIOGEN INC | 8.95 | 21.31B | ||
| SMMT | SUMMIT THERAPEUTICS INC | N/A | 16.49B |
Related stock screener links
About CRGX
Company Profile
Cargo Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in the development of cell therapies for cancer patients. The company is headquartered in San Carlos, California and currently employs 116 full-time employees. The company went IPO on 2023-11-10. The firm is engaged in advancing curative cell therapies for cancer patients. Its programs, platform technologies, and manufacturing strategy are designed to directly address the chimeric antigen receptor (CAR) T-cell therapies. The CAR is a protein that has been engineered to modify T cells so they can recognize and destroy cancer cells. The Company’s lead program, firicabtagene autoleucel (CRG-022), is an autologous (derived from a patient’s cells) CD22 CAR T-cell product candidate. The firm is also engaged in evaluating CRG-022 in patients at earlier stages of disease, including large B-cell lymphoma (LBCL) and other hematologic malignancies. The firm is also leveraging its proprietary cell engineering platform technologies to develop a pipeline of programs that incorporate multiple transgene therapeutic designed by the Company to enhance CAR T-cell persistence and trafficking to tumor lesions.
Company Info
CARGO THERAPEUTICS INC
835 Industrial Road, Suite 400
San Carlos CALIFORNIA US
Employees: 150
Company Website: https://cargo-tx.com
Investor Relations: http://cargo-tx.com/about/investors/
Phone: 16504998950
CRGX FAQ
What is the stock price of CRGX?
The current stock price of CRGX is 3.39 USD.
What is the symbol for CARGO THERAPEUTICS INC stock?
The exchange symbol of CARGO THERAPEUTICS INC is CRGX and it is listed on the Nasdaq exchange.
On which exchange is CRGX stock listed?
CRGX stock is listed on the Nasdaq exchange.
Is CRGX a good stock to buy?
Always make your own analysis. On these pages you can find a full technical and fundamental analysis report for CRGX, which may be a starting point for your analysis. You can also find the financials, news, analyst ratings and estimates here, which can be used to increase your understanding of CRGX.
Does CRGX stock pay dividends?
CRGX does not pay a dividend.
What is the Price/Earnings (PE) ratio of CRGX?
CRGX does not have a PE ratio as the earnings reported over the last twelve months were negative (-4.26).
What is the Short Interest ratio of CRGX stock?
The outstanding short interest for CRGX is 17.33% of its float.
CRGX Technical Analysis
CRGX Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to CRGX. No worries on liquidiy or solvency for CRGX as it has an excellent financial health rating, but there are worries on the profitability.
CRGX Financial Highlights
Over the last trailing twelve months CRGX reported a non-GAAP Earnings per Share(EPS) of -4.26. The EPS decreased by -124.71% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -34.18% | ||
| ROE | -38.45% | ||
| Debt/Equity | 0 |
CRGX Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 84% to CRGX. The Buy consensus is the average rating of analysts ratings from 15 analysts.